Position in MGTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$40,148,369
+$10,135,416 QoQ
Shares Held
2,971,752
-14.3% QoQ
Ownership
3.09%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#8
of 156 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGTX Over Time
Shares Held
Position Value (USD)
Derivatives in MGTX
reported options exposure · as of Sep 30, 2025CallValue
$92,999
CallShares
11,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. MGTX ranks #26 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in MGTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,148,369 | 2,971,752 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $30,012,953 | 3,465,699 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $25,252,300 | 3,176,390 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,076,774 | 2,560,969 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $92,999 | 11,300 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $5,119,380 | 785,181 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $297,526 | 48,855 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $377,643 | 90,562 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $262,636 | 62,384 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,764,973 | 290,770 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $947,524 | 134,975 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $201,149 | 29,933 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $158,915 | 30,738 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $73,773 | 11,315 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $492,363 | 58,545 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $744,040 | 98,288 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,157,956 | 83,607 | Shares | Sole | 2022-05-16 | |
| 2021-03-31 | $578,253 | 40,073 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,397,164 | 92,283 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $159,304 | 12,724 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||